Pulmonx Corporation Common Stock (LUNG) is a publicly traded Healthcare sector company. As of July 16, 2026, LUNG trades at $1.45 with a market cap of $62.51M and a P/E ratio of -1.12. LUNG moved -2.36% today. Year to date, LUNG is -34.84%; over the trailing twelve months it is -46.67%. Its 52-week range spans $1.13 to $9.37. Analyst consensus is strong buy with an average price target of $3.50. Rallies surfaces LUNG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
4 analysts cover LUNG: 0 strong buy, 3 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $3.50.
| Metric | Value |
|---|---|
| Price | $1.45 |
| Market Cap | $62.51M |
| P/E Ratio | -1.12 |
| EPS | $-1.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.37 |
| 52-Week Low | $1.13 |
| Volume | 93.25K |
| Avg Volume | 0 |
| Revenue (TTM) | $88.55M |
| Net Income | $-53.21M |
| Gross Margin | 75.49% |
4 analysts cover LUNG: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $3.50.